| Ms Marilyn Lynne Hines, DO | |
|
1921 Stonecipher Dr, Ada, OK 74820 | |
| (580) 436-3980 | |
| Not Available |
| Full Name | Ms Marilyn Lynne Hines |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 1921 Stonecipher Dr, Ada, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942217336 | NPI | - | NPPES |
| 100221300F | Medicaid | OK | |
| 100708090C | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 3113 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mays Housecall Home Health Of Ada, Llc | Ada, OK | Home health agency |
| Chickasaw Nation Medical Center | Ada, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chickasaw Nation Division Of Health | 8426957523 | 209 |
News Archive
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary clinical trial led by Johns Hopkins Kimmel Cancer Center scientists.
Top experts from around the country will be at the University of North Carolina at Chapel Hill later this week to teach athletic trainers and medical providers how to prevent deaths and serious injuries among high school and college athletes.
Researchers at the University of California, San Diego School of Medicine report in the August 10 issue of Pediatric Infectious Disease Journal that a significant number of pediatric physicians fail to diagnose Kawasaki disease in children younger than six months and older than eight years.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
HIV is spreading in New York City at about three times the national rate, with an incidence of 72 new HIV infections per 100,000 people, compared with 23 new infections per 100,000 people nationwide, according to a study released Wednesday by the New York City Department of Health and Mental Hygiene, the New York Times reports (Chan, New York Times, 8/28).
› Verified 5 days ago
| Entity Name | Chickasaw Nation Division Of Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255364923 PECOS PAC ID: 8426957523 Enrollment ID: O20040108000364 |
News Archive
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary clinical trial led by Johns Hopkins Kimmel Cancer Center scientists.
Top experts from around the country will be at the University of North Carolina at Chapel Hill later this week to teach athletic trainers and medical providers how to prevent deaths and serious injuries among high school and college athletes.
Researchers at the University of California, San Diego School of Medicine report in the August 10 issue of Pediatric Infectious Disease Journal that a significant number of pediatric physicians fail to diagnose Kawasaki disease in children younger than six months and older than eight years.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
HIV is spreading in New York City at about three times the national rate, with an incidence of 72 new HIV infections per 100,000 people, compared with 23 new infections per 100,000 people nationwide, according to a study released Wednesday by the New York City Department of Health and Mental Hygiene, the New York Times reports (Chan, New York Times, 8/28).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Marilyn Lynne Hines, DO 1921 Stonecipher Dr, Ada, OK 74820-3439 Ph: (580) 436-3980 | Ms Marilyn Lynne Hines, DO 1921 Stonecipher Dr, Ada, OK 74820 Ph: (580) 436-3980 |
News Archive
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary clinical trial led by Johns Hopkins Kimmel Cancer Center scientists.
Top experts from around the country will be at the University of North Carolina at Chapel Hill later this week to teach athletic trainers and medical providers how to prevent deaths and serious injuries among high school and college athletes.
Researchers at the University of California, San Diego School of Medicine report in the August 10 issue of Pediatric Infectious Disease Journal that a significant number of pediatric physicians fail to diagnose Kawasaki disease in children younger than six months and older than eight years.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
HIV is spreading in New York City at about three times the national rate, with an incidence of 72 new HIV infections per 100,000 people, compared with 23 new infections per 100,000 people nationwide, according to a study released Wednesday by the New York City Department of Health and Mental Hygiene, the New York Times reports (Chan, New York Times, 8/28).
› Verified 5 days ago
David Frow, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Dr, Ada, OK 74820 Phone: 580-436-3980 Fax: 580-421-6283 | |
Dr. Joshua Priddle, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 905 Colony Dr, Ada, OK 74820 Phone: 580-436-5111 Fax: 580-436-1159 | |
Dr. Joanne Chinnici, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2513 Timber Ter, Ada, OK 74820 Phone: 580-399-7716 | |
Marc J Davis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 530 N Monte Vista St, Suite A, Ada, OK 74820 Phone: 580-310-9510 Fax: 580-436-4447 | |
Curtis E Harris, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 905 Colony Dr, Ada, OK 74820 Phone: 580-436-5111 Fax: 580-436-1159 | |
Patrick Mason, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Boulevard, Ada, OK 74820 Phone: 580-421-4570 Fax: 580-421-6286 | |
Patrick J O'neill, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1150 North Hills Centre, Ada, OK 74820 Phone: 580-332-8606 Fax: 580-332-8616 |